Surgical Strategies and Methods for the Treatment of Metastasizing Medullary Thyroid Carcinoma

  • H. J. Buhr
  • F. Kallinowski
  • C. Herfarth
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 125)

Abstract

The medullary thyroid carcinoma (MTC) exhibits several biological peculiarities. The early formation of metastases in the local lymph nodes of the neck region and of the proximal mediastinum is of particular importance for the development of therapeutic regimens (Bergholm et al. 1989; Buhr et al. 1991; Duh et al. 1989; Graze et al. 1978). Considering patients with elevated basal calcitonin values which were detected during family screening programs Wells et al. (1978b) demonstrated in 50% a lymph node involvement. Patients with clinically manifest tumors suffered in 71% from local metastases. Similarly, metastases in the neck lymph nodes were found in 9% and mediastinal secondaries in 8% of patients with clinically occult familial C-cell carcinomas characterized by normal basal calcitonin levels but pathological elevations upon pentagastrin stimulation. The prognostic relevance of lymph node metastases is demonstrated by the classic work of Woolner et al. (1969). The 10-year survival rate of patients without lymph node involvement reached 85% and was not significantly different to a reference population. In patients with lymph node involvement it was significantly reduced to 42%. These reports were further substantiated by other authors (Bergholm et al. 1989; Roka et al. 1982; Saad et al. 1984; Schröder et al. 1988; Wahl et al. 1987). Since distant metastases occur only late in the natural history of the disease, surgical eradication of lymph node metastases can prolong the patient’s life and even achieve higher cure rates (Tisell et al. 1986). Since the tumor cells are relatively radio- and chemoresistant, surgical intervention is highly indicated (Pertursson 1988; Samaan et al. 1988; Scherübl et al. 1990).

Keywords

Catheter Assure Hunt Calcitonin Adriamycin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bergholm U, Adami HO, Bergstrom R, Johansson H, Lundell G, Telenius-Berg M, Akerström G (1989) Clinical characteristics in sporadic and familial medullary thyroid carcinoma. Cancer 63: 1196–1204PubMedCrossRefGoogle Scholar
  2. Block MA, Jackson CHE, Tashjian AH (1978) Management of occult medullary thyroid carcinoma. Arch Surg 113: 368–372PubMedCrossRefGoogle Scholar
  3. Block MA, Jackson CE, Greenwald KA, Yott JB, Tashjian AH (1980) Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment complications. Arch Surg 115: 142–148Google Scholar
  4. Böckdahl M, Tallroth E, Auer G, Forsslund G, Grawberg PO, Lundell G, Löwhagen G (1985) Prognostic value of nuclear DNA content in medullary thyroid carcinoma. World J Surg 9: 980–987CrossRefGoogle Scholar
  5. Buhr HJ, Lehnert T, Raue F (1990) New operative strategy in the treatment of metastasizing medullary carcinoma of the thyroid. Eur J Surg Oncol 16: 366–369PubMedGoogle Scholar
  6. Buhr HJ, Raue F, Herfarth C (1991) Spezielle Tumorbiologie and Chirurgie des C-Cell-Carcinoms. Chirurg 62: 529–535PubMedGoogle Scholar
  7. Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary thyroid carcinoma of the thyroid gland. Cancer 35: 695–704PubMedCrossRefGoogle Scholar
  8. DeLellis RA, Rule AH, Spiler I, Nathason I, Tashjian AH, Wolfe I (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70: 587–591Google Scholar
  9. Duh QY, Sancho JJ, Greenspan FS, Hunt TK, Galante M, de Lorimier AA, Conte FA, Clark OH (1989) Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 124: 1206–1210Google Scholar
  10. Eickhoff W, Herberhold C (1968) Die Lymphbahnen der menschlichen Schilddrüse. Springer, Berlin Heidelberg New YorkGoogle Scholar
  11. Gautwick KM, Talle K, Hager B, Jorgensen OG, Aas M (1989) Early liver metastases in patients with medullary carcinoma of the thyroid gland. Cancer 63: 175–180CrossRefGoogle Scholar
  12. Goltzmann D, Potts JT, Ridgeway EC, Maloof F (1974) Calcitonin as a tumor marker. N Engl J Med 290: 1035–1039CrossRefGoogle Scholar
  13. Graze K, Spiler IJ, Tashjian AH, Melvin KEW, Cervi-Skinner S, Gagel RF, Miller HH, Wolfe HJ, DeLellis RA, Leape L, Feldman ZT, Reichlin S (1978) Natural history of familial medullary thyroid carcinoma. N Engl J Med 299: 980–985PubMedCrossRefGoogle Scholar
  14. Mrad MDB, Gardet P, Roche A, Rougier PL, Calmettes C, Motte PL, Parmetier C (1989) Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma. Cancer 63: 133 —138Google Scholar
  15. Norton JA, Doppman JL, Brennan MF (1980) Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87: 616–622PubMedGoogle Scholar
  16. Pertursson SR (1988) Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil. Cancer 62: 1899–1903CrossRefGoogle Scholar
  17. Raue F (1985) Diagnostik des medullären Schilddrüsencarcinoms. Dtsch Med Wochenschr 110: 1334–1337PubMedCrossRefGoogle Scholar
  18. Raue F, Schmidt-Gayk H, Ziegler R (1983) Tumormarker beim C-Zell-Karzinom. Dtsch Med Wochenschr 108: 283–287PubMedCrossRefGoogle Scholar
  19. Roka R, Niederle B, Fritsch A, Krisch K, Schemper M (1982) Chirurgische TherapieGoogle Scholar
  20. des medullären Schilddrüsenkarzinoms. Dtsch Med Wochenschr 107:132–138 Rossi RL, Cady B, Meissner WA, Wool MS, Sedgwich CE, Werber J (1980)Google Scholar
  21. Nonfamilial medullary thyroid carcinoma. Am J Surg 139:554–560Google Scholar
  22. Russell CF, van Heerden JA, Sizemore GW, Edis JA, Taylor WF, Remine WH, Carney JA (1983) The surgical management of medullary thyroid carcinoma. Ann Surg 197: 42–48PubMedGoogle Scholar
  23. Saad MF, Ordonez NG, Rashid RK (1984) Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 63: 319–342Google Scholar
  24. Samaan NA, Schultz PN, Hickey RC (1988) Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 67: 801–805PubMedCrossRefGoogle Scholar
  25. Scherübl H, Raue F, Ziegler R (1990) Kombinationstherapie von Adriamycin, Cisplatin and Vindesin beim C-Zell-Karzinom der Schilddrüse. Onkologie 13: 198–202Google Scholar
  26. Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G (1988) Prognostic factors in medullary thyroid carcinomas. Cancer 61: 806–816PubMedCrossRefGoogle Scholar
  27. Schwerk WB, Grün R, Wahl R (1985) Ultrasound diagnosis of C-cell carcinoma of the thyroid. Cancer 55: 624–630PubMedCrossRefGoogle Scholar
  28. Simeone J, Daniels G, Müller P (1982) High resolution real time ultrasonography of the thyroid. Radiology 145: 431–435PubMedGoogle Scholar
  29. Telander RL, Zimmerman D, van Heerden JA, Sizemere GW (1986) Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2. J Pediatr Surg 21: 1190–1194PubMedCrossRefGoogle Scholar
  30. Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99: 60–66PubMedGoogle Scholar
  31. Van Heerden JA, Grant CS, Gharib H, Hay JD, Ilstrup DM (1990) Longterm course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212: 395–401PubMedCrossRefGoogle Scholar
  32. Wahl RA, Branscheid D, Goretzki PE, Röher HD (1987) Chirurgische Therapie des C-Zell-Karzinoms. In: Wörner W, Reimers C (eds) Schilddrüsenmalignome, Diagnostik, Therapie and Nachsorge. Schattauer, Stuttgart, pp 267–280Google Scholar
  33. Wells SA, Haagensen DE, Lineham WH, Farrell RE, Dilley WG (1978a) The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42: 1498–1503PubMedCrossRefGoogle Scholar
  34. Wells SA, Bauglin SB, Gamm DS, Farrell RE, Dilley WG, Preissig SH, Lineham WM, Cooper CW (1978b) Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 188: 377–383PubMedCrossRefGoogle Scholar
  35. Wells SA, Baylin SB, Leight GS, Dale J, Dilley WG, Farndon JR (1982) The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg 195: 595–599PubMedCrossRefGoogle Scholar
  36. Woolner LB, Beahrs OH, Black MB, McCanahey WM, Keating FR (1969) Longterm survival rates. UICC Monogr Ser 12: 326–330Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1992

Authors and Affiliations

  • H. J. Buhr
    • 1
  • F. Kallinowski
    • 1
  • C. Herfarth
    • 1
  1. 1.Abteilung 2.1, Chirurgische UniversitätsklinikKlinikum der UniversitätHeidelbergGermany

Personalised recommendations